Close

Neos Therapeutics (NEOS) Announces Submission of NT-0201 NDA to U.S. FDA

Go back to Neos Therapeutics (NEOS) Announces Submission of NT-0201 NDA to U.S. FDA
(NASDAQ: NEOS) Delayed: 1.15 --0 (-0%)
Previous Close $1.15    52 Week High $16.46 
Open $0.16    52 Week Low $5.30 
Day High $1.15    P/E N/A 
Day Low $1.15    EPS $0.00 
Volume